Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

News headlines Recursion Pharmaceuticals (RXRX) is preparing to report its first-quarter 2026 results on May 6. The company is focusing on its AI-driven drug discovery platform while navigating ...

Add this event to your calendar to attend our Office Hours. These sessions aim to inform Northwestern faculty and their research teams. On this Zoom session on April 15, we will host breakout rooms ...

The U.S.-China trade war, which began during Trump’s first term, has reverberated across the global economy. But experts say fully decoupling the world’s two largest economies is likely impossible.

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

This article was originally published on CFR.org and updated by NBC News. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

The global water agenda is outdated and narrow and is framed mainly as a downstream impact sector. Scientists must step up to help the world recognize water as an opportunity sector and to design a ...